JPMorgan Starts Evolent Health (EVH) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $4.04 +2.02%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
JPMorgan initiated coverage on Evolent Health (NYSE: EVH) with an Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Evolent Health click here. For more ratings news on Evolent Health click here.
Shares of Evolent Health closed at $18.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026
- Chardan Starts Duos Technologies Group (DUOT) at Neutral
- Maxim Group Starts The RMR Group Inc. (RMR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
